Catalent Inc. (CTLT) News
Filter CTLT News Items
CTLT News Results
|Loading, please wait...|
CTLT News Highlights
- For CTLT, its 30 day story count is now at 20.
- Over the past 5 days, the trend for CTLT's stories per day has been choppy and unclear. It has oscillated between 1 and 9.
- The most mentioned tickers in articles about CTLT are DRUG, PRE and GLP.
Latest CTLT News From Around the Web
Below are the latest news stories about CATALENT INC that investors may wish to consider to help them evaluate CTLT as an investment opportunity.
RESEARCH REPORTS These reports, excerpted and edited by Barron’s, were issued recently by investment and research firms. The reports are a sampling of analysts’ thinking; they should not be considered the views or recommendations of Barron’s.
The headline numbers for Catalent (CTLT) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Catalent, Inc. (NYSE:CTLT) Q1 2024 Earnings Call Transcript November 15, 2023 Catalent, Inc. beats earnings expectations. Reported EPS is $-0.1, expectations were $-0.13. Operator: Hello all, and welcome to Catalent’s First Quarter Fiscal Year 2024 Earnings Call. My name is Lydia and I’ll be your operator today. [Operator Instructions]. I’ll now hand you over to […]
Catalent (CTLT) records lower revenues in Biologics segments in its first-quarter fiscal 2024, resulting in overall soft preliminary performance.
Investing.com -- U.S. stocks were falling as the steam ran out of their recent rally after Walmart's cautious outlook on consumer spending.
Wall Street closed higher on Wednesday after a sharp rally in the previous day.
Catalent (CTLT) expects the demand for its pre-filled syringes to improve going forward. The company anticipates the majority of its pre-filled syringe production capacity to be booked until fiscal 2026.
Q1 2024 Catalent Inc Earnings Call
Syringe maker Catalent said it expects to benefit from soaring demand for injectable weight-loss drugs, and shares surged.
The S&P 500 posted gains of 0.2% on Wednesday, Nov. 15, 2023, with positive inflation news helping send U.S. equities higher.